Cargando…
Menopausal Status Combined with Serum CA125 Level Significantly Predicted Concurrent Endometrial Cancer in Women Diagnosed with Atypical Endometrial Hyperplasia before Surgery †
About 10–66% of patients with atypical endometrial hyperplasia diagnosed before surgery (preoperative-AEH) are found to have concurrent endometrial cancer (EC) at definitive hysterectomy, leading to incomplete primary surgery and delayed adjuvant treatment. This study aims to investigate the potenti...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775082/ https://www.ncbi.nlm.nih.gov/pubmed/35054175 http://dx.doi.org/10.3390/diagnostics12010006 |
_version_ | 1784636496393797632 |
---|---|
author | Lou, Yaochen Liao, Jiongbo Shan, Weiwei Xu, Zhiying Chen, Xiaojun Guan, Jun |
author_facet | Lou, Yaochen Liao, Jiongbo Shan, Weiwei Xu, Zhiying Chen, Xiaojun Guan, Jun |
author_sort | Lou, Yaochen |
collection | PubMed |
description | About 10–66% of patients with atypical endometrial hyperplasia diagnosed before surgery (preoperative-AEH) are found to have concurrent endometrial cancer (EC) at definitive hysterectomy, leading to incomplete primary surgery and delayed adjuvant treatment. This study aims to investigate the potential risk factors of concurrent EC in preoperative-AEH patients in a clinical setting with a gynecological pathology review. All patients diagnosed with AEH by endometrial biopsy or curettage that then underwent definitive hysterectomy from January 2016 to December 2019 in a tertiary hospital were retrospectively analyzed. All diagnoses were reviewed by gynecological pathologists. A total of 624 preoperative-AEH patients were included, 30.4% of whom had concurrent EC. In multivariate analysis, postmenopausal status and CA125 ≥ 35 U/mL significantly correlated with concurrent EC (OR = 3.57; 95% CI = 1.80–7.06; OR = 2.15; 95% CI = 1.15–4.03). This risk was remarkably increased in patients with both postmenopausal status and CA125 ≥ 35 U/mL (OR = 16.20; 95% CI = 1.73–151.44). Notably, concurrent EC seemed to occur more frequently in women with postmenopausal time ≥ 5 years (OR = 4.04, 95% CI = 1.80–5.85). In addition, CA125 ≥ 35 U/mL seemed to be an independent risk factor (OR = 5.74; 95% CI = 1.80–18.27) for concurrent intermediate-high-risk EC. Intermediate-high-risk EC was also more commonly seen in preoperative-AEH women with postmenopausal time ≥ 5 years (OR = 5.52, 95% CI = 1.21–25.19, p = 0.027). In conclusion, preoperative-AEH patients with postmenopausal status or elevated level of CA125 might have a high risk of concurrent EC. Adequate pre-surgical evaluation might be suggested for such patients. |
format | Online Article Text |
id | pubmed-8775082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87750822022-01-21 Menopausal Status Combined with Serum CA125 Level Significantly Predicted Concurrent Endometrial Cancer in Women Diagnosed with Atypical Endometrial Hyperplasia before Surgery † Lou, Yaochen Liao, Jiongbo Shan, Weiwei Xu, Zhiying Chen, Xiaojun Guan, Jun Diagnostics (Basel) Article About 10–66% of patients with atypical endometrial hyperplasia diagnosed before surgery (preoperative-AEH) are found to have concurrent endometrial cancer (EC) at definitive hysterectomy, leading to incomplete primary surgery and delayed adjuvant treatment. This study aims to investigate the potential risk factors of concurrent EC in preoperative-AEH patients in a clinical setting with a gynecological pathology review. All patients diagnosed with AEH by endometrial biopsy or curettage that then underwent definitive hysterectomy from January 2016 to December 2019 in a tertiary hospital were retrospectively analyzed. All diagnoses were reviewed by gynecological pathologists. A total of 624 preoperative-AEH patients were included, 30.4% of whom had concurrent EC. In multivariate analysis, postmenopausal status and CA125 ≥ 35 U/mL significantly correlated with concurrent EC (OR = 3.57; 95% CI = 1.80–7.06; OR = 2.15; 95% CI = 1.15–4.03). This risk was remarkably increased in patients with both postmenopausal status and CA125 ≥ 35 U/mL (OR = 16.20; 95% CI = 1.73–151.44). Notably, concurrent EC seemed to occur more frequently in women with postmenopausal time ≥ 5 years (OR = 4.04, 95% CI = 1.80–5.85). In addition, CA125 ≥ 35 U/mL seemed to be an independent risk factor (OR = 5.74; 95% CI = 1.80–18.27) for concurrent intermediate-high-risk EC. Intermediate-high-risk EC was also more commonly seen in preoperative-AEH women with postmenopausal time ≥ 5 years (OR = 5.52, 95% CI = 1.21–25.19, p = 0.027). In conclusion, preoperative-AEH patients with postmenopausal status or elevated level of CA125 might have a high risk of concurrent EC. Adequate pre-surgical evaluation might be suggested for such patients. MDPI 2021-12-21 /pmc/articles/PMC8775082/ /pubmed/35054175 http://dx.doi.org/10.3390/diagnostics12010006 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lou, Yaochen Liao, Jiongbo Shan, Weiwei Xu, Zhiying Chen, Xiaojun Guan, Jun Menopausal Status Combined with Serum CA125 Level Significantly Predicted Concurrent Endometrial Cancer in Women Diagnosed with Atypical Endometrial Hyperplasia before Surgery † |
title | Menopausal Status Combined with Serum CA125 Level Significantly Predicted Concurrent Endometrial Cancer in Women Diagnosed with Atypical Endometrial Hyperplasia before Surgery † |
title_full | Menopausal Status Combined with Serum CA125 Level Significantly Predicted Concurrent Endometrial Cancer in Women Diagnosed with Atypical Endometrial Hyperplasia before Surgery † |
title_fullStr | Menopausal Status Combined with Serum CA125 Level Significantly Predicted Concurrent Endometrial Cancer in Women Diagnosed with Atypical Endometrial Hyperplasia before Surgery † |
title_full_unstemmed | Menopausal Status Combined with Serum CA125 Level Significantly Predicted Concurrent Endometrial Cancer in Women Diagnosed with Atypical Endometrial Hyperplasia before Surgery † |
title_short | Menopausal Status Combined with Serum CA125 Level Significantly Predicted Concurrent Endometrial Cancer in Women Diagnosed with Atypical Endometrial Hyperplasia before Surgery † |
title_sort | menopausal status combined with serum ca125 level significantly predicted concurrent endometrial cancer in women diagnosed with atypical endometrial hyperplasia before surgery † |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775082/ https://www.ncbi.nlm.nih.gov/pubmed/35054175 http://dx.doi.org/10.3390/diagnostics12010006 |
work_keys_str_mv | AT louyaochen menopausalstatuscombinedwithserumca125levelsignificantlypredictedconcurrentendometrialcancerinwomendiagnosedwithatypicalendometrialhyperplasiabeforesurgery AT liaojiongbo menopausalstatuscombinedwithserumca125levelsignificantlypredictedconcurrentendometrialcancerinwomendiagnosedwithatypicalendometrialhyperplasiabeforesurgery AT shanweiwei menopausalstatuscombinedwithserumca125levelsignificantlypredictedconcurrentendometrialcancerinwomendiagnosedwithatypicalendometrialhyperplasiabeforesurgery AT xuzhiying menopausalstatuscombinedwithserumca125levelsignificantlypredictedconcurrentendometrialcancerinwomendiagnosedwithatypicalendometrialhyperplasiabeforesurgery AT chenxiaojun menopausalstatuscombinedwithserumca125levelsignificantlypredictedconcurrentendometrialcancerinwomendiagnosedwithatypicalendometrialhyperplasiabeforesurgery AT guanjun menopausalstatuscombinedwithserumca125levelsignificantlypredictedconcurrentendometrialcancerinwomendiagnosedwithatypicalendometrialhyperplasiabeforesurgery |